biomed-evidence-synthesizer
Synthesize biomedical evidence across multiple studies, including randomized trials, observational cohorts, case reports, animal models, in vitro experiments, longitudinal studies, and meta-analyses.
SKILL.md.claude/skills/biomed-evidence-synthesizer/SKILL.md
GitHubBiomedical Evidence Synthesizer
Integrate multiple biomedical studies into a balanced conclusion. Use this when the user has several papers, mixed evidence, conflicting results, or a broad question that requires weighing clinical, observational, animal, and mechanistic data together.
Step 0: Frame the Evidence Question
Write the question as:
In [population/context], does [exposure/intervention/mechanism] affect
[endpoint/outcome], compared with [control/comparator], over [time scale]?
If needed, split one broad question into mechanistic, efficacy, safety, and translation subquestions.
Step 1: Build the Evidence Table
Group studies by type:
- Systematic reviews and meta-analyses.
- Randomized controlled trials.
- Nonrandomized interventional studies.
- Prospective cohorts.
- Retrospective cohorts and case-control studies.
- Case reports and case series.
- Animal studies.
- Ex vivo, organoid, in vitro, biochemical, and computational studies.
- Trial registry records and regulatory reviews.
For each study, extract:
- Population/model.
- Exposure/intervention and comparator.
- Dose, route, timing, duration, and follow-up.
- Endpoint type: clinical, surrogate, biomarker, mechanistic, safety.
- Effect direction and magnitude.
- Statistical uncertainty.
- Main limitations.
Step 2: Compare Studies
Check whether studies are actually asking the same question. Differences that often explain disagreement:
- Disease subtype or stage.
- Age, sex, comorbidities, baseline risk, and concomitant therapies.
- Species, strain, tissue, cell line, or model system.
- Dose, formulation, route, timing, and treatment duration.
- Acute versus chronic exposure.
- Primary versus secondary endpoints.
- Surrogate versus clinical endpoints.
- Adjustment for confounding.
- Follow-up length.
- Publication bias, selective outcome reporting, and sponsor effects.
Step 3: Grade the Body of Evidence
Assess:
- Consistency: are effects in the same direction?
- Replication: independent groups, populations, and methods.
- Precision: sample size, uncertainty intervals, event counts.
- Directness: does evidence answer the actual clinical or mechanistic question?
- Bias risk: randomization, blinding, confounding, attrition, selective reporting.
- Dose-response and temporal relationship.
- Biological plausibility without over-weighting mechanism.
- Safety and adverse event evidence.
Use these conclusion labels:
- Clinically established.
- Clinically supported but incomplete.
- Promising but preliminary.
- Mechanistically plausible but clinically unproven.
- Mixed or inconclusive.
- Unsupported.
- Contradicted by stronger evidence.
Step 4: Resolve Conflicts
When studies disagree, do not average them rhetorically. Identify whether the conflict is likely due to:
- Study quality.
- Different populations or models.
- Different endpoints.
- Different doses or timing.
- Chance, underpowering, or multiple testing.
- Confounding or bias.
- Real biological heterogeneity.
Say which explanation is most plausible and why.
Step 5: Output
Use this structure:
# Evidence Synthesis: [Question]
## Bottom Line
[One cautious paragraph with evidence grade.]
## Evidence by Study Type
[Short summary grouped by evidence type.]
## Cross-Study Comparison
| Study | Type | Population/Model | Exposure | Endpoint | Result | Key Limitation |
|------|------|------------------|----------|----------|--------|----------------|
## Areas of Agreement
[Findings replicated or directionally consistent.]
## Areas of Conflict
[Contradictions and plausible explanations.]
## Human Clinical Relevance
[Whether evidence reaches human clinical endpoints.]
## Safety Evidence
[Known adverse events, missing safety data, follow-up limitations.]
## Most Plausible Interpretation
[Reasoned synthesis, not a vote count.]
## What Would Change the Conclusion
[Specific future study designs, endpoints, or missing data.]
Standards
- Weight stronger designs more heavily, but do not ignore consistent lower-level evidence.
- Do not equate mechanistic coherence with clinical proof.
- Do not bury heterogeneity; explain it.
- Treat unpublished completed trials and terminated trials as important signals when relevant.
- Keep causality claims proportional to design quality.